SilkTech Biopharmaceuticals

0 followers


SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Their lead indication is Dry Eye Disease, an inflammatory-based chronic condition.

Industries

Employees

11-50

Links


Org chart

Brian Lawrence
Chief Executive Officer
Collapse
David Infanger
VP, Research & Development
Eric D. Donnenfeld
Founding Partner Of Ophthalmic Consultants Of Connecticut
Richard L. Lindstrom
Founding Partner Of Minnesota Eye Consultants
Edward Holland
Director Of Cornea Services At Cincinnati Eye Institute

Board & advisors

Brian Levy
Executive Chairman
Alex Soltani
Board Member
Bill Mower
Board Member
Emmett Cunningham
Board Member
Paul M. Karpecki
Board Member